Obesity

Genetic Diagnosis of Endocrine Disorders

Volumn , Issue , 2010, Pages

  Dubern, Beatrice ^a,b   Tounian, Patrick ^a,b   Clément, Karine ^a,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Genetics; Leptin; Melanocortin 4 receptor; Melanocortins; Obesity; Proopiomelanocortin

Indexed keywords

EID: 84860394026     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374430-2.00003-1     Document Type: Chapter

References (68)

1. Kimm S.Y., Barton B.A., Obarzanek E., et al. Obesity development during adolescence in a biracial cohort: the NHLBI Growth and Health Study. Pediatrics 2002, 110:e54.
2. Sorensen T.I. The genetics of obesity. Metabolism 1995, 44:4-6.
3. Farooqi I.S. Genetic aspects of severe childhood obesity. Pediatr. Endocrinol. Rev. 2006, 3(Suppl. 4):528-536.
4. Chung W.K., Leibel R.L. Molecular physiology of syndromic obesities in humans. Trends Endocrinol. Metab. 2005, 16:267-272.
5. Farooqi I.S., O'Rahilly S. Monogenic obesity in humans. Annu. Rev. Med. 2005, 56:443-458.
6. Harrold J.A., Williams G. Melanocortin-4 receptors, beta-MSH and leptin: key elements in the satiety pathway. Peptides 2006, 27:365-371.
7. Strosberg A.D., Issad T. The involvement of leptin in humans revealed by mutations in leptin and leptin receptor genes. Trends Pharmacol. Sci. 1999, 20:227-230.
8. Montague C.T., Farooqi I.S., Whitehead J.P., et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997, 387:903-908.
9. Clement K., Vaisse C., Lahlou N., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998, 392:398-401.
10. Krude H., Biebermann H., Schnabel D., et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J. Clin. Endocrinol. Metab. 2003, 88:4633-4640.
11. Jackson R.S., Creemers J.W., Ohagi S., et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 1997, 16:303-306.
12. Jackson R.S., Creemers J.W., Farooqi I.S., et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J. Clin. Invest. 2003, 112:1550-1560.
13. Farooqi I.S. Genetic and hereditary aspects of childhood obesity. Best Pract. Res. Clin. Endocrinol. Metab. 2005, 19:359-374.
14. Farooqi I.S., Wangensteen T., Collins S., et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N. Engl. J. Med. 2007, 356:237-247.
15. Farooqi I.S., Drop S., Clements A., et al. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 2006, 55:2549-2553.
16. Carroll L., Voisey J., van Daal A. Gene polymorphisms and their effects in the melanocortin system. Peptides 2005, 26:1871-1885.
17. Holder J.L., Butte N.F., Zinn A.R. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum. Mol. Genet. 2000, 9:101-108.
18. Michaud J.L., Boucher F., Melnyk A., et al. Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum. Mol. Genet. 2001, 10:1465-1473.
19. Kublaoui B.M., Holder J.L., Gemelli T., et al. Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. Mol. Endocrinol. 2006, 20:2483-2492.
20. Kernie S.G., Liebl D.J., Parada L.F. BDNF regulates eating behavior and locomotor activity in mice. Embo. J. 2000, 19:1290-1300.
21. Xu B., Goulding E.H., Zang K., et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci. 2003, 6:736-742.
22. Yeo G.S., Connie Hung C.C., Rochford J., et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat. Neurosci. 2004, 7:1187-1189.
23. Gray J., Yeo G., Hung C., et al. Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity. Int. J. Obes. (Lond.) 2007, 31:359-364.
24. Govaerts C., Srinivasan S., Shapiro A., et al. Obesity-associated mutations in the melanocortin 4 receptor provide novel insights into its function. Peptides 2005, 26:1909-1919.
25. Lubrano-Berthelier C., Dubern B., Lacorte J.M., et al. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J. Clin. Endocrinol. Metab. 2006, 91:1811-1818.
26. Hinney A., Bettecken T., Tarnow P., et al. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J. Clin. Endocrinol. Metab. 2006, 91:1761-1769.
27. Farooqi I.S., Keogh J.M., Yeo G.S., et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 2003, 348:1085-1095.
28. Lubrano-Berthelier C., Le StunffC., Bougneres P., et al. A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans. J. Clin. Endocrinol. Metab. 2004, 89:2028-2032.
29. Dubern B., Bisbis S., Talbaoui H., et al. Homozygous null mutation of the melanocortin-4 receptor and severe early-onset obesity. J. Pediatr. 2007, 150:613-617. 617 e1.
30. Vaisse C., Clement K., Durand E., et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 2000, 106:253-262.
31. MacKenzie R.G. Obesity-associated mutations in the human melanocortin-4 receptor gene. Peptides 2006, 27:395-403.
32. Elefteriou F., Ahn J.D., Takeda S., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
33. Ahn J.D., Dubern B., Lubrano-Berthelier C., et al. Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology 2006, 147:3196-3202.
34. Branson R., Potoczna N., Kral J.G., et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N. Engl. J. Med. 2003, 348:1096-1103.
35. Mergen M., Mergen H., Ozata M., et al. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J. Clin. Endocrinol. Metab. 2001, 86:3448.
36. Lubrano-Berthelier C., Durand E., Dubern B., et al. Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum. Mol. Genet. 2003, 12:145-153.
37. Nijenhuis W.A., Oosterom J., Adan R.A. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 2001, 15:164-171.
38. Srinivasan S., Lubrano-Berthelier C., Govaerts C., et al. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J. Clin. Invest. 2004, 114:1158-1164.
39. Horsthemke B., Buiting K. Imprinting defects on human chromosome 15. Cytogenet. Genome. Res. 2006, 113:292-299.
40. Goldstone A.P. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol. Metab. 2004, 15:12-20.
41. Cummings D.E., Clement K., Purnell J.Q., et al. Elevated plasma ghrelin levels in Prader-Willi syndrome. Nat. Med. 2002, 8:643-644.
42. Franzese A., Romano A., Spagnuolo M.I., et al. Growth hormone therapy in children with Prader-Willi syndrome. J. Pediatr. 2006, 148:846. author reply 846-7.
43. Carrel A.L., Moerchen V., Myers S.E., et al. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. J. Pediatr. 2004, 145:744-749.
44. Katsanis N., Lupski J.R., Beales P.L. Exploring the molecular basis of Bardet-Biedl syndrome. Hum. Mol. Genet. 2001, 10:2293-2299.
45. Stoetzel C., Laurier V., Davis E.E., et al. BBS10 encodes a vertebrate 3945-specific chaperonin-like protein and is a major BBS locus. Nat. Genet. 2006, 38:521-524.
46. Nishimura D.Y., Swiderski R.E., Searby C.C., et al. Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene. Am. J. Hum. Genet. 2005, 77:1021-1033.
47. Chiang A.P., Beck J.S., Yen H.J., et al. Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc. Natl. Acad. Sci. USA 2006, 103:6287-6292.
48. Eichers E.R., Lewis R.A., Katsanis N., et al. Triallelic inheritance: a bridge between Mendelian and multifactorial traits. Ann. Med. 2004, 36:262-272.
49. Slavotinek A.M., Searby C., Al-Gazali L., et al. Mutation analysis of the MKKS gene in McKusick-Kaufman syndrome and selected Bardet-Biedl syndrome patients. Hum. Genet. 2002, 110:561-567.
50. Fan Y., Esmail M.A., Ansley S.J., et al. Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome. Nat. Genet. 2004, 36:989-993.
51. Badano J.L., Mitsuma N., Beales P.L., et al. The ciliopathies: an emerging class of human genetic disorders. Annu. Rev. Genomics. Hum. Genet. 2006, 7:125-148.
52. Kolehmainen J., Black G.C., Saarinen A., et al. Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am. J. Hum. Genet. 2003, 72:1359-1369.
53. Seifert W., Holder-Espinasse M., Spranger S., et al. Mutational spectrum of COH1 and clinical heterogeneity in Cohen syndrome. J. Med. Genet. 2006, 43:e22.
54. Farooqi I.S., Matarese G., Lord G.M., et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 2002, 110:1093-1103.
55. Licinio J., Caglayan S., Ozata M., et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc. Natl. Acad. Sci. USA 2004, 101:4531-4536.
56. Williamson D.A., Ravussin E., Wong M.L., et al. Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy. Appetite 2005, 45:75-80.
57. Sleeman M.W., Anderson K.D., Lambert P.D., et al. The ciliary neurotrophic factor and its receptor, CNTFR alpha. Pharm. Acta Helv. 2000, 74:265-272.
58. Preti A. Axokine (Regeneron). IDrugs 2003, 6:696-701.
59. Sariola H. The neurotrophic factors in non-neuronal tissues. Cell. Mol. Life Sci. 2001, 58:1061-1066.
60. Irani B.G., Xiang Z., Moore M.C., et al. Voluntary exercise delays monogenetic obesity and overcomes reproductive dysfunction of the melanocortin-4 receptor knockout mouse. Biochem. Biophys. Res. Commun. 2005, 326:638-644.
61. Xiang Z., Pogozheva I.D., Sorenson N.B., et al. Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms. Biochemistry 2007, 46:8273-8287.
62. Ujjainwalla F., Sebhat I.K. Small molecule ligands of the human melanocortin-4 receptor. Curr. Top. Med. Chem. 2007, 7:1068-1084.
63. Carrel A.L., Myers S.E., Whitman B.Y., et al. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study. J. Pediatr. 1999, 134:215-221.
64. Festen D.A., de Lind van Wijngaarden R., van Eekelen M., et al. Randomized controlled growth hormone trial: effects on anthropometry, body composition, and body proportions in a large group of children with Prader-Willi syndrome. Clin. Endocrinol. (Oxf.) 2008, 69(3):443-451.
65. Strobel A., Issad T., Camoin L., et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 1998, 18:213-215.
66. Krude H., Biebermann H., Luck W., et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 1998, 19:155-157.
67. Biebermann H., Castaneda T.R., van Landeghem F., et al. A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 2006, 3:141-146.
68. Lee Y.S., Challis B.G., Thompson D.A., et al. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006, 3:135-140.